List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 12 studies with search of: at1001
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Open Label Long-Term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
Condition: Fabry Disease
Intervention: Drug: AT1001
2 Active, not recruiting Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
Condition: Celiac Disease
Interventions: Drug: larazotide acetate (AT-1001);   Drug: placebo
3 Completed Safety and Tolerability Study of AT1001 in Celiac Disease Subjects
Condition: Celiac Disease
Intervention: Drug: AT1001
4 Completed A Study of AT1001 in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
5 Completed A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
6 Completed A 12-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
7 Completed A 12-Week Safety and Pharmacodynamic Study of AT1001 in Female Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
8 Recruiting Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: migalastat hydrochloride;   Drug: Placebo
9 Active, not recruiting Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide acetate (AT1001);   Drug: Placebo
10 Completed Safety Study of AT1001 to Treat Celiac Disease.
Condition: Celiac Disease
Intervention: Drug: AT-1001
11 Active, not recruiting Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: AT-1001;   Drug: placebo
12 Completed Safety of AT-1001 in Healthy Volunteers
Condition: Healthy
Intervention: Drug: AT-1001

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services